Aardvark Therapeutics Inc (AARD)

SG&A Expenses

$18.90M

TTM · Period ending: · USD

AARD logo

AARD SG&A Expenses

Latest reported$18.90M
AARD TTM SG&A Expenses ($3.95M → $18.90M)
High-resolution chart · PNG

AARD sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aardvark Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
18,897,000
16,971,000
13,789,000
10,772,000
7,832,000
7,159,000
5,305,000
4,442,000
3,954,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.